CVS Beats Estimates, Raises EPS Guidance
CVS Caremark Corp. (NYSE: CVS) reported third-quarter 2012 earnings this morning. The pharmacy benefits management and retail sales firm posted adjusted diluted earnings per share (EPS) of $0.85 on revenues ...Read Full Story »






